Chagas' heart disease: gender differences in myocardial damage assessed by cardiovascular magnetic resonance

Antonildes N Assunção1, Michael Jerosch-Herold2, Rodrigo L Melo1

  • 1Heart Institute, InCor, University of Sao Paulo Medical School, Cardiovascular Magnetic Resonance and Computed Tomography Sector, Av. Dr. Enéas de Carvalho Aguiar, 44, Andar AB, Cerqueira César, São Paulo, SP, 05403-000, Brazil.

Insights

Men with Chagas' heart disease show greater myocardial fibrosis and dysfunction than women. Cardiovascular magnetic resonance (CMR) revealed significant gender differences in myocardial damage, potentially explaining poorer male prognosis.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Medical Research

Background:

  • Chagas' heart disease is associated with higher cardiovascular morbidity and mortality in males.
  • Previous reports suggest gender disparities in Chagas' heart disease outcomes.
  • Investigating gender differences in myocardial damage is crucial for understanding disease progression.

Purpose of the Study:

  • To investigate gender differences in myocardial damage in Chagas' heart disease patients.
  • To assess myocardial damage using cardiovascular magnetic resonance (CMR).
  • To explore the relationship between gender, myocardial fibrosis, and left ventricular ejection fraction.

Main Methods:

  • Retrospective analysis of 62 seropositive Chagas' heart disease patients.
  • Cardiovascular magnetic resonance (CMR) imaging at 1.5 T was performed.
  • Analysis included correlation between left ventricular ejection fraction and myocardial fibrosis, adjusting for confounders.

Main Results:

  • Males exhibited significantly greater myocardial fibrosis and lower left ventricular ejection fraction compared to females.
  • Myocardial fibrosis mediated 53% of the association between gender and myocardial dysfunction.
  • Transmural pattern and myocardial heterogeneity were more prevalent in male patients.

Conclusions:

  • Significant gender-related differences in myocardial damage were observed in Chagas' heart disease patients via CMR.
  • Myocardial fibrosis and dysfunction are linked to cardiovascular outcomes.
  • These findings may elucidate the poorer prognosis observed in males with Chagas' disease.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
603
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
524
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
698
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
362
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
743
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
862